Novo Nordisk

Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market

Motley Fool

Thu, 04/6/23 - 11:29 am

Novo Nordisk

diabetes

Ozempic

Rybelsus

Biopharma stocks go back to bleak

EP Vantage

Thu, 04/6/23 - 09:51 am

Albireo Pharma

Amryt Pharma

Apellis Pharmaceuticals

Protagonist Therapeutics

Provention Bio

Reata Pharmaceuticals

Regeneron

Sanofi

Seagen

Diabesity drugs and their free ‘contract sales force’

Medical Marketing and Media

Tue, 04/4/23 - 10:12 am

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

CP Wire

Mon, 04/3/23 - 03:35 pm

CVS Health

Signify Health

M&A

Ferring Pharmaceuticals

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

Mon, 04/3/23 - 03:33 pm

CVS Health

Signify Health

M&A

Ferring Pharmaceuticals

CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations

Endpoints

Sun, 04/2/23 - 04:17 pm

Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries

Fierce Pharma

Mon, 03/27/23 - 11:23 am

The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win

Investors Business Daily

Sun, 03/26/23 - 11:28 pm

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

CP Wire

Sun, 03/26/23 - 03:44 pm

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Sun, 03/26/23 - 03:36 pm

In insulin resistance pact, Dewpoint adds Novo Nordisk to its pharma-rich pipeline

Enpoints

Wed, 03/22/23 - 11:13 am

Dewpoint Therapeutics

Six-month Ozempic shortage mostly over after weight-loss craze drained supply

Seattle Times, WA

Mon, 03/20/23 - 04:39 pm

Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs

Endpoints

Thu, 03/16/23 - 09:16 pm

Novo Nordisk suspended from ABPI after code breach

Pharmaphorum

Thu, 03/16/23 - 09:30 am

Novo Nordisk

ABPI

Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly

BioSpace

Wed, 03/15/23 - 10:06 am

Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly

Forbes

Tue, 03/14/23 - 11:27 am

Covering new weight loss drugs could strain Medicare, policy experts warn

Stat

Sun, 03/12/23 - 09:54 pm

Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices

Fierce Pharma

Sun, 03/5/23 - 03:26 pm

Big Pharma regained ‘mojo’ last year, but biotech valuations remain ‘precarious’: report

Fierce Biotech

Sun, 03/5/23 - 03:06 pm

Search form

You are here

Novo Nordisk

Pages